These data point out that the expression of PD-L1 by tumor cells and presence of surrounding immune cells with a lower ability to present tumor antigens for CD8 and CD4 T cell activation could be considered complementary mechanisms to evade immune surveillance in presence of high systemic inflammation levels. The gene discussed is CD8A; the disease is neoplasm.